Suppr超能文献

同步原发性子宫内膜癌和卵巢癌患者的临床病理特征:43例病例回顾

Clinicopathological characteristics of patients with synchronous primary endometrial and ovarian cancers: A review of 43 cases.

作者信息

Liu Yuantao, Li Jun, Jin Hongyan, Lu Ying, Lu Xin

机构信息

Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, P.R. China.

出版信息

Oncol Lett. 2013 Jan;5(1):267-270. doi: 10.3892/ol.2012.943. Epub 2012 Sep 27.

Abstract

Synchronous primary endometrial and ovarian cancers are uncommon. The purpose of this study was to evaluate the clinicopathological characteristics, treatment and prognosis of synchronous primary endometrial and ovarian cancers. The clinicopathological characteristics of 43 patients with synchronous primary endometrial and ovarian cancers in the Obstetrics and Gynecology Hospital of Fudan University between 1999 and 2009 were retrospectively reviewed. Our results revealed that the median age at the time of diagnosis was 51 years (range, 29-71). The common presenting symptoms were abnormal uterine bleeding (AUB, 65.12%), abdominal mass (25.58%), abdominal pain and abdominal fullness (39.53%). An elevated CA125 level was observed in the majority of patients (n=20, 76.9%). Endometrioid type accounted for 60.47% of uterine carcinomas and different pathological types, including serous adenocarcinoma, clear cell carcinoma, adenosquamous and acanthoadenocarcinoma, were also identified in synchronous primary endometrial and ovarian cancers. All patients underwent surgical intervention (hysterectomy and bilateral salpingo-oophorectomy with pelvic lymphadenectomy or debulking surgery). The 5-year survival rate was 86.05% and nine patients had recurrence (20.93%). The early stage group (FIGO stages I and II) had more favorable prognosis than the advanced stage group (FIGO stages III and IV; P<0.05). In conclusion, synchronous primary endometrial and ovarian cancers are different from either primary endometrial carcinoma or ovarian cancer and are usually identified at early stages with a good prognosis.

摘要

同步性原发性子宫内膜癌和卵巢癌并不常见。本研究的目的是评估同步性原发性子宫内膜癌和卵巢癌的临床病理特征、治疗及预后。回顾性分析了1999年至2009年期间复旦大学附属妇产科医院43例同步性原发性子宫内膜癌和卵巢癌患者的临床病理特征。我们的结果显示,诊断时的中位年龄为51岁(范围29 - 71岁)。常见的临床表现为异常子宫出血(AUB,65.12%)、腹部肿块(25.58%)、腹痛和腹胀(39.53%)。大多数患者(n = 20,76.9%)CA125水平升高。子宫内膜样型占子宫癌的60.47%,同步性原发性子宫内膜癌和卵巢癌中还发现了不同的病理类型,包括浆液性腺癌、透明细胞癌、腺鳞癌和棘腺癌。所有患者均接受了手术干预(子宫切除术、双侧输卵管卵巢切除术加盆腔淋巴结清扫术或肿瘤细胞减灭术)。5年生存率为86.05%,9例患者复发(20.93%)。早期组(FIGO分期I和II期)的预后比晚期组(FIGO分期III和IV期;P<0.05)更有利。总之,同步性原发性子宫内膜癌和卵巢癌不同于原发性子宫内膜癌或卵巢癌,通常在早期被发现,预后良好。

相似文献

4
[Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
Zhonghua Fu Chan Ke Za Zhi. 2022 May 25;57(5):352-360. doi: 10.3760/cma.j.cn112141-20220214-00086.
5
Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
J Obstet Gynaecol Res. 2015 Nov;41(11):1813-9. doi: 10.1111/jog.12826. Epub 2015 Sep 14.
6
[Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Zhonghua Fu Chan Ke Za Zhi. 2018 Dec 25;53(12):816-822. doi: 10.3760/cma.j.issn.0529-567x.2018.12.004.
7
Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases.
Am J Surg Pathol. 1994 Apr;18(4):364-75. doi: 10.1097/00000478-199404000-00005.
8
Synchronous primary ovarian and endometrial cancers: a series of cases and a review of literature.
Prz Menopauzalny. 2014 Mar;13(1):64-9. doi: 10.5114/pm.2014.41084. Epub 2014 Mar 10.
9
The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.
Arch Gynecol Obstet. 2019 Oct;300(4):1045-1052. doi: 10.1007/s00404-019-05288-5. Epub 2019 Sep 14.
10
Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
Gynecol Oncol. 2004 Aug;94(2):456-62. doi: 10.1016/j.ygyno.2004.05.006.

引用本文的文献

1
Outcomes and prognostic factors in patients with synchronous endometrial and ovarian cancer.
Arch Gynecol Obstet. 2025 Sep 4. doi: 10.1007/s00404-025-08164-7.
2
Synchronous primary endometrium and ovarian carcinoma: A case report.
Clin Case Rep. 2022 Oct 8;10(10):e6432. doi: 10.1002/ccr3.6432. eCollection 2022 Oct.
3
How to manage synchronous endometrial and ovarian cancer patients?
BMC Cancer. 2021 May 1;21(1):489. doi: 10.1186/s12885-021-08220-w.
7
Hydrosalpinx as a Rare Presentation of Synchronous Ovarian and Endometrial Carcinoma - A Case Report.
J Clin Diagn Res. 2016 Jul;10(7):QD01-3. doi: 10.7860/JCDR/2016/18304.8102. Epub 2016 Jul 1.
8
Endometriosis: pathogenesis and treatment.
Nat Rev Endocrinol. 2014 May;10(5):261-75. doi: 10.1038/nrendo.2013.255. Epub 2013 Dec 24.

本文引用的文献

1
Synchronous early-stage endometrial and ovarian cancer.
Int J Gynaecol Obstet. 2008 Jul;102(1):34-8. doi: 10.1016/j.ijgo.2007.12.012. Epub 2008 Mar 17.
2
Synchronous primary cancers of the endometrium and ovary.
Int J Gynecol Cancer. 2008 Jan-Feb;18(1):159-64. doi: 10.1111/j.1525-1438.2007.00975.x. Epub 2007 May 15.
5
Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
Gynecol Oncol. 2004 Aug;94(2):456-62. doi: 10.1016/j.ygyno.2004.05.006.
10
Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons.
Cancer. 1983 Sep 15;52(6):1026-31. doi: 10.1002/1097-0142(19830915)52:6<1026::aid-cncr2820520617>3.0.co;2-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验